View Clinical Trial (Medical Research Study)
Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression
| City: |
|
Boston |
| State: |
|
Massachusetts |
| Zip Code: |
|
02114 |
| Conditions: |
|
Suicidal Ideation - Major Depressive Disorder |
| Purpose: |
|
Harley and colleagues demonstrated that adding Dialectical Behavior Therapy (DBT)
skills-groups and therapist consultation to treatment as usual successfully reduced symptoms
of depression. The present study will expand upon these findings. Second, DBT is not known
for reducing suicidal ideation (SI), a major risk factor for suicide . The present study
will tailor the aforementioned skills-groups to specifically target suicidal thoughts and
behaviors through Cognitive Behavior Therapy (CBT) strategies aimed at increasing
problem-solving deficits, hopelessness, and negativistic thinking. Third, the present study
will extend this DBT-based approach to a novel population. Fourth, the present study is the
first DBT intervention to employ state-of-the-art multi-method measurement (including
objective assessment) of suicidal thoughts and behaviors.
The investigators hypothesize that participants in the DBT skills (DBT-S) group will show
improvements in level of suicidality as measured by decreased scores on the Beck Scale for
Suicide Ideation as compared with participants in the Wait List-Treatment as Usual (WL-TAU)
group.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. Participants will be at least 18 years of age.
2. Participants will meet criteria for Major Depressive Disorder (MDD) on the Structured
Clinical Interviews for Axis I DSM-IV Disorders
3. Participants must report current suicidal ideation on the Self-Injurious Thoughts and
Behaviors Interview
4. Participants must have an outpatient psychiatric provider who they see "regularly"
(i.e., at least every other week for therapy, case management, or medication
management).
5. English language proficiency.
Exclusion Criteria:
1. DSM-IV diagnosis of bipolar disorder, schizophrenia, psychotic disorder NOS, or
personality disorders.
2. Active current substance dependence.
3. Severe or unstable medical conditions that would prohibit regular group attendance or
participation.
4. Other group therapy.
5. Significant dementia or cognitive impairment that would interfere with the learning
of DBT skills.
|
| NCT ID: |
|
NCT01441258 |
| Primary Contact: |
|
Principal Investigator
Maurizio Fava, MD
Massachusetts General Hospital
Kate A Hails, B.A.
Phone: 617-643-7690
Email: khails@partners.org
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Boston, Massachusetts 02114
United States
Kiki Fehling, BA
Phone: 617-726-3129
Email: kfehling@partners.org
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 17, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|